2.01 USD
▲+0.03+1.52%
盘后 2.02 +0.50%
2026-09-15
市值
$898.81M
市盈率
—
EPS
-0.16
股息率
—
52 周区间
1.06 – 2.68
成交量
2.51M
Beta
1.03
目标价
3.86
52W 低 1.0652W 高 2.68
价格走势
公司简介
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart fail...